IP Verse

Amorphous Lercanidipine Hydrochloride - EP1856051

PATENT ANALYSIS

Patent Details

Grant Date
Nov 13, 2019
Company
RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A.
Oppositions

ELKINGTON AND FIFE LLP

FRESENIUS KABI DEUTSCHLAND GMBH

GLENMARK LIFE SCIENCES LIMITED

HEUMANN PHARMA GMBH & CO. GENERICA KG

LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB

SANDOZ AG

STADA ARZNEIMITTEL AG

More patents of Recordati Industria Chimica E Farmaceutica S.P.A.

EP1856051

Want to monitor this patent?

Feel free to send us a message here and we will get back to you